|
1
|
Chen Z, Fillmore CM, Hammerman PS, Kim CF
and Wong KK: Non-small-cell lung cancers: A heterogeneous set of
diseases. Nat Rev Cancer. 14:535–546. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhou X, Li D, Wang X, Zhang B, Zhu H and
Zhao J: Galectin-1 is overexpressed in CD133+ human lung
adenocarcinoma cells and promotes their growth and invasiveness.
Oncotarget. 6:3111–3122. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Goyette MA and Côté JF: NSCLC metastasis:
Going with ELMO3. Oncotarget. 5:5850–5851. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Filippova M, Filippov V, Williams VM,
Zhang K, Kokoza A, Bashkirova S and Duerksen-Hughes P: Cellular
levels of oxidative stress affect the response of cervical cancer
cells to chemotherapeutic agents. Biomed Res Int. 2014:5746592014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Suzuki S, Okada M, Shibuya K, Seino M,
Sato A, Takeda H, Seino S, Yoshioka T and Kitanaka C: JNK
suppression of chemotherapeutic agents-induced ROS confers
chemoresistance on pancreatic cancer stem cells. Oncotarget.
6:458–470. 2015.
|
|
6
|
Khojastehfar A, Aghaei M, Gharagozloo M
and Panjehpour M: Cadmium induces reactive oxygen species-dependent
apoptosis in MCF-7 human breast cancer cell line. Toxicol Mech
Methods. 25:48–55. 2015. View Article : Google Scholar
|
|
7
|
Huang H, Shah K, Bradbury NA, Li C and
White C: Mcl-1 promotes lung cancer cell migration by directly
interacting with VDAC to increase mitochondrial Ca2+
uptake and reactive oxygen species generation. Cell Death Dis.
5:e14822014. View Article : Google Scholar
|
|
8
|
Joh HM, Choi JY, Kim SJ, Chung TH and Kang
TH: Effect of additive oxygen gas on cellular response of lung
cancer cells induced by atmospheric pressure helium plasma jet. Sci
Rep. 4:66382014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jung KH, Lee JH, Thien Quach CH, Paik JY,
Oh H, Park JW, Lee EJ, Moon SH and Lee KH: Resveratrol suppresses
cancer cell glucose uptake by targeting reactive oxygen
species-mediated hypoxia-inducible factor-1α activation. J Nucl
Med. 54:2161–2167. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fortunato O, Boeri M, Verri C, Moro M and
Sozzi G: Therapeutic use of microRNAs in lung cancer. Biomed Res
Int. 2014:7569752014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen L and Jin H: MicroRNAs as novel
biomarkers in the diagnosis of non-small cell lung cancer: A
meta-analysis based on 20 studies. Tumour Biol. 35:9119–9129. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cortinovis D, Monica V, Pietrantonio F,
Ceresoli GL, La Spina CM and Wannesson L: MicroRNAs in non-small
cell lung cancer: Current status and future therapeutic promises.
Curr Pharm Des. 20:3982–3990. 2014. View Article : Google Scholar
|
|
13
|
Del Vescovo V, Grasso M, Barbareschi M and
Denti MA: MicroRNAs as lung cancer biomarkers. World J Clin Oncol.
5:604–620. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fortunato O, Boeri M, Verri C, Conte D,
Mensah M, Suatoni P, Pastorino U and Sozzi G: Assessment of
circulating microRNAs in plasma of lung cancer patients. Molecules.
19:3038–3054. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gao Y, Gao F, Ma JL, Sun WZ and Song LP:
The potential clinical applications and prospects of microRNAs in
lung cancer. Onco Targets Ther. 7:901–906. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu SH, Zhang CL, Dong FS and Zhang YM:
miR-99a suppresses the metastasis of human non-small cell lung
cancer cells by targeting AKT1 signaling pathway. J Cell Biochem.
116:268–276. 2015. View Article : Google Scholar
|
|
17
|
Wu D, Zhou Y, Pan H, Zhou J, Fan Y and Qu
P: microRNA-99a inhibiting cell proliferation, migration and
invasion by targeting fibroblast growth factor receptor 3 in
bladder cancer. Oncol Lett. 7:1219–1224. 2014.PubMed/NCBI
|
|
18
|
Gu W, Fang S, Gao L, Tan Y and Yang Z:
Clinic significance of microRNA-99a expression in human lung
adenocarcinoma. J Surg Oncol. 108:248–255. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen C, Zhao Z, Liu Y and Mu D:
microRNA-99a is downregulated and promotes proliferation, migration
and invasion in non-small cell lung cancer A549 and H1299 cells.
Oncol Lett. 9:1128–1134. 2015.PubMed/NCBI
|
|
20
|
Zhang C, Kang C, Wang P, Cao Y, Lv Z, Yu
S, Wang G, Zhang A, Jia Z, Han L, et al: MicroRNA-221 and -222
regulate radiation sensitivity by targeting the PTEN pathway. Int J
Radiat Oncol Biol Phys. 80:240–248. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chun-Zhi Z, Lei H, An-Ling Z, Yan-Chao F,
Xiao Y, Guang-Xiu W, Zhi-Fan J, Pei-Yu P, Qing-Yu Z and Chun-Sheng
K: MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell
proliferation and radioresistance by targeting PTEN. BMC Cancer.
10:3672010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang C, Zhang J, Hao J, Shi Z, Wang Y,
Han L, Yu S, You Y, Jiang T, Wang J, et al: High level of
miR-221/222 confers increased cell invasion and poor prognosis in
glioma. J Transl Med. 10:1192012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Song Y, Dou H, Wang P, Zhao S, Wang T,
Gong W, Zhao J, Li E, Tan R and Hou Y: A novel small-molecule
compound diaporine A inhibits non-small cell lung cancer growth by
regulating miR-99a/mTOR signaling. Cancer Biol Ther. 15:1423–1430.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang Z, Han Y, Cheng K, Zhang G and Wang
X: miR-99a directly targets the mTOR signalling pathway in breast
cancer side population cells. Cell Prolif. 47:587–595. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jiang H, Qu L, Wang Y, Cong J, Wang W and
Yang X: miR-99a promotes proliferation targeting FGFR3 in human
epithelial ovarian cancer cells. Biomed Pharmacother. 68:163–169.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang H, Zhu Y, Zhao M, Wu C, Zhang P, Tang
L, Zhang H, Chen X, Yang Y and Liu G: miRNA-29c suppresses lung
cancer cell adhesion to extracellular matrix and metastasis by
targeting integrin β1 and matrix metalloproteinase2 (MMP2). PLoS
One. 8:e701922013. View Article : Google Scholar
|
|
27
|
Chen PM, Wu TC, Shieh SH, Wu YH, Li MC,
Sheu GT, Cheng YW, Chen CY and Lee H: MnSOD promotes tumor invasion
via upregulation of FoxM1-MMP2 axis and related with poor survival
and relapse in lung adenocarcinomas. Mol Cancer Res. 11:261–271.
2013. View Article : Google Scholar
|
|
28
|
Kogo R, How C, Chaudary N, Bruce J, Shi W,
Hill RP, Zahedi P, Yip KW and Liu FF: The microRNA-218~Survivin
axis regulates migration, invasion, and lymph node metastasis in
cervical cancer. Oncotarget. 6:1090–1100. 2015. View Article : Google Scholar :
|
|
29
|
Zhang Y, Zhao FJ, Chen LL, Wang LQ, Nephew
KP, Wu YL and Zhang S: miR-373 targeting of the Rab22a oncogene
suppresses tumor invasion and metastasis in ovarian cancer.
Oncotarget. 5:12291–12303. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang C, Lan T, Hou J, Li J, Fang R, Yang
Z, Zhang M, Liu J and Liu B: NOX4 promotes non-small cell lung
cancer cell proliferation and metastasis through positive feedback
regulation of PI3K/Akt signaling. Oncotarget. 5:4392–4405. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li Y, Han N, Yin T, Huang L, Liu S, Liu D,
Xie C and Zhang M: Lentivirus-mediated Nox4 shRNA invasion and
angiogenesis and enhances radiosensitivity in human glioblastoma.
Oxid Med Cell Longev. 2014:5817322014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Boudreau HE, Casterline BW, Rada B,
Korzeniowska A and Leto TL: Nox4 involvement in TGF-beta and
SMAD3-driven induction of the epithelial-to-mesenchymal transition
and migration of breast epithelial cells. Free Radic Biol Med.
53:1489–1499. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zha L, Chen J, Sun S, Mao L, Chu X, Deng
H, Cai J, Li X, Liu Z and Cao W: Soyasaponins can blunt
inflammation by inhibiting the reactive oxygen species-mediated
activation of PI3K/Akt/NF-κB pathway. PLoS One. 9:e1076552014.
View Article : Google Scholar
|
|
34
|
Lee KR, Lee JS, Song JE, Ha SJ and Hong
EK: Inonotus obliquus-derived polysaccharide inhibits the migration
and invasion of human non-small cell lung carcinoma cells via
suppression of MMP-2 and MMP-9. Int J Oncol. 45:2533–2540.
2014.PubMed/NCBI
|
